Literature DB >> 984766

In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.

R E Reese, R F Betts, L W Goedde, R G Douglas.   

Abstract

The in vitro susceptibility of 145 anaerobic clinical isolates and 96 gram-positive aerobic clinical isolates to josamycin, a new macrolide antibiotic, was studied using the agar dilution technique. Ninety-five of the aerobes were susceptible to 1.56 mug or less of josamycin per ml. The median minimal inhibitory concentration of these organisms was </=0.39 mug/ml. The in vitro activity of josamycin against the anaerobes was compared with that of erythromycin, clindamycin, penicillin, and chloramphenicol. At concentrations </=3.12 mug/ml, 100% of strains of Bacteroides species and Bacteroides fragilis were susceptible to josamycin. At low concentrations (</=0.39 mug/ml), clindamycin was more active than josamycin against the anaerobes. However, at concentrations </=3.12 mug/ml, the activities of josamycin and clindamycin were similar except against the Fusobacterium species, which was quite resistant to josamycin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984766      PMCID: PMC429731          DOI: 10.1128/AAC.10.2.253

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  Clindamycin--efficacy and toxicity.

Authors:  R I Frankel
Journal:  West J Med       Date:  1975-06

2.  In vitro susceptibility studies with josamycin and erythromycin.

Authors:  L J Strausbaugh; J A Dilworth; J M Gwaltney; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

Review 3.  Chloramphenicol-induced bone marrow suppression.

Authors:  A A Yunis
Journal:  Semin Hematol       Date:  1973-07       Impact factor: 3.851

4.  Clindamycin-associated colitis. A prospective study.

Authors:  F J Tedesco; R W Barton; D H Alpers
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

5.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

6.  Bacterial studies of Clindamycin-associated colitis. A preliminary report.

Authors:  J J Marr; M D Sans; F J Tedesco
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

7.  Management of anaerobic infections.

Authors:  S M Finegold; J G Bartlett; A W Chow; D J Flora; S L Gorbach; E J Harder; F P Tally
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

8.  Pseudomembranous enterocolitis. Resurgence related to newer antibiotic therapy.

Authors:  E B Keeffe; R M Katon; T T Chan; C S Melnyk; J A Benson
Journal:  West J Med       Date:  1974-12
  8 in total
  1 in total

1.  New medium selective for Fusobacterium species and differential for Fusobacterium necrophorum.

Authors:  A A Morgenstein; D M Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.